These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23446503)
21. Perceptions of contralateral breast cancer: an overestimation of risk. Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590 [TBL] [Abstract][Full Text] [Related]
22. Predictors of and satisfaction with bilateral prophylactic mastectomy. Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy. Chagpar AB Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342 [TBL] [Abstract][Full Text] [Related]
24. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829 [TBL] [Abstract][Full Text] [Related]
25. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. van Dijk S; van Roosmalen MS; Otten W; Stalmeier PF J Clin Oncol; 2008 May; 26(14):2358-63. PubMed ID: 18467728 [TBL] [Abstract][Full Text] [Related]
26. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956 [TBL] [Abstract][Full Text] [Related]
27. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability. Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798 [TBL] [Abstract][Full Text] [Related]
28. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab). Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874 [TBL] [Abstract][Full Text] [Related]
30. Prophylactic mastectomy: who needs it, when and why. Burke EE; Portschy PR; Tuttle TM J Surg Oncol; 2015 Jan; 111(1):91-5. PubMed ID: 24965368 [TBL] [Abstract][Full Text] [Related]
31. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy. Murphy RX; Adkinson JM; Namey T; Eid S; Bleznak A Ann Plast Surg; 2010 May; 64(5):684-7. PubMed ID: 20395792 [TBL] [Abstract][Full Text] [Related]
32. Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. Fisher CS; Martin-Dunlap T; Ruppel MB; Gao F; Atkins J; Margenthaler JA Ann Surg Oncol; 2012 Oct; 19(10):3246-50. PubMed ID: 22833001 [TBL] [Abstract][Full Text] [Related]
33. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA; J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327 [TBL] [Abstract][Full Text] [Related]
34. Can women with early-stage breast cancer make an informed decision for mastectomy? Collins ED; Moore CP; Clay KF; Kearing SA; O'Connor AM; Llewellyn-Thomas HA; Barth RJ; Sepucha KR J Clin Oncol; 2009 Feb; 27(4):519-25. PubMed ID: 19114703 [TBL] [Abstract][Full Text] [Related]
35. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004 [TBL] [Abstract][Full Text] [Related]
36. Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy. McQuirter M; Castiglia LL; Loiselle CG; Wong N Oncol Nurs Forum; 2010 May; 37(3):313-20. PubMed ID: 20439215 [TBL] [Abstract][Full Text] [Related]
37. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy. Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282 [TBL] [Abstract][Full Text] [Related]
38. Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities. Bloom DL; Chapman BM; Wheeler SB; McGuire KP; Lee CN; Weinfurt K; Rosenstein DL; Plichta JK; Jacobson Vann JC; Hwang ES Psychooncology; 2019 Feb; 28(2):394-400. PubMed ID: 30500102 [TBL] [Abstract][Full Text] [Related]
39. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour. Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679 [TBL] [Abstract][Full Text] [Related]
40. Increasing mastectomy rates-the effect of environmental factors on the choice for mastectomy: a comparative analysis between Canada and the United States. Covelli AM; Baxter NN; Fitch MI; Wright FC Ann Surg Oncol; 2014 Oct; 21(10):3173-84. PubMed ID: 25081340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]